This company is no longer actively trading as an independent public company (delisted, acquired, or ceased operations). This profile is retained for reference.
Field Trip Health & Wellness Ltd. is a global leader in psychedelic therapies. With health centres across North America and Europe, along with the digital and technological tools that will enable massive scale, we help people in need with a simple, evidence-based way to heal and heighten engagement with the world.
Stock Performance
Field Trip Health & Wellness News 48 articles
- What Can The Industry Learn From Field Trip Health’s Downfall?
- Weekly Extractions featuring Atai and Field Trip
- Field Trip Health & Wellness Obtains CCAA Protection
- Field Trip Health & Wellness to Close Clinics in 5 Locations
- Field Trip Health & Wellness Provides Business Update and Reports Fiscal Third Quarter 2023 Results
- Field Trip Health & Wellness Ltd. to Release Fiscal 2023 Third Quarter Financial Results on Tuesday, February 28, 2023
- Field Trip Health & Wellness Ltd. Announces Launch of Online Therapy
- Field Trip Health & Wellness To Webcast Live at the KCSA Mental Health Conference on December 15th
- Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call
- Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call
- Field Trip Announces the Launch of Freedom by Field Trip™, a First-of-Its-Kind Ketamine Therapy Program
- Field Trip Health & Wellness to Participate in Upcoming November Conferences
- Field Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic App
- Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results
- Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET
- Field Trip Announces First Dosings in Phase I Clinical Study of FT-104
- Field Trip’s Full Year 2022 Financial and Pipeline Analysis – Bullish vs Bearish: Episode #2
- Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home
- PRO: Last Week in Review – Field Trip, Oregon, Psilocybin, and More
- Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
- Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
- Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care
- A Closer Look At Field Trip Health’s (FTRP) Latest Earnings
- Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
- Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
- Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
- Field Trip Health opens Europe’s first psychedelic therapy healthcare facility
- Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers
- Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
- Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”
- Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
- Field Trip Health Ltd. Receives Conditional Approval to Up-List to the TSX
- Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston
- OTC Markets Group Welcomes Field Trip Health Ltd. to OTCQX
- Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
- Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform
- Here’s Where Field Trip Health is Opening Locations Next
- Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations
- Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
- Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program
Showing the 40 most recent of 48 articles.